The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction.
Niamh Keegan
No relevant relationships to disclose
Fionnuala Keane
No relevant relationships to disclose
Sinead Cuffe
No relevant relationships to disclose
Moya Cunningham
No relevant relationships to disclose
Narayanasamy Ravi
No relevant relationships to disclose
Geraldine Lee
No relevant relationships to disclose
M. John Kennedy
No relevant relationships to disclose
William Grogan
No relevant relationships to disclose
Brian O'Neill
No relevant relationships to disclose
Derek G. Power
No relevant relationships to disclose
Gregory Leonard
No relevant relationships to disclose
Maccon M. Keane
No relevant relationships to disclose
Cormac Small
No relevant relationships to disclose
Imelda Parker
No relevant relationships to disclose
Brian Moulton
No relevant relationships to disclose
Seamus O'Reilly
No relevant relationships to disclose
John Vincent Reynolds
No relevant relationships to disclose